Posted On: 08/02/2016 1:48:52 PM
Post# of 4
Great Overview Article on $BSTG Biostage Inc. in Worcester Business Journal on August 1st, 2016
Holliston Biotech Seeks to fulfill $1.5-billion potential
Discusses current research and plans to file and IND with the FDA to initiate human clinical trials of its Cellspan esophageal organ implant.
Holliston Biotech Seeks to fulfill $1.5-billion potential
Discusses current research and plans to file and IND with the FDA to initiate human clinical trials of its Cellspan esophageal organ implant.
(0)
(0)
Posts that I make on Investors Hangout reflect my own personal thinking and opinion and are neither endorsed nor approved by the subject companies, many of which may be clients or client prospects of our our NY-based investor relations consulting firm.
David Collins, Managing Director
Catalyst Global Investor Relations
www.catalyst-ir.com
dcc@catatalyst-ir.com
212 924 9800
David Collins, Managing Director
Catalyst Global Investor Relations
www.catalyst-ir.com
dcc@catatalyst-ir.com
212 924 9800
